ZOMZomedica Corp.

NYSE zomedica.com


$ 0.13 $ 0.00 (1.9 %)    

Friday, 30-Aug-2024 15:56:19 EDT
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 0.1289
$ 0.13 x 300
-- x --
-- - --
$ 0.12 - $ 0.23
2,095,521
na
126.32M
$ 1.20
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-15-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 02-26-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-10-2019 03-31-2019 10-Q
23 02-26-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 02-28-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 zomedica-announced-that-its-assisi-loop-product-line-is-continuing-its-designation-as-a-fear-free-preferred-product

Fear Free, a globally recognized initiative dedicated to reducing fear, anxiety, and stress in pets, reaffirmed its validation ...

 zomedica-q2-eps-001-down-from-001-yoy-sales-613m-miss-626m-estimate

Zomedica (AMEX:ZOM) reported quarterly losses of $(0.01) per share. This is a 100 percent decrease over losses of $(0.01) per s...

 zomedica-taps-into-costa-rica-with-strategic-partnership-with-sire-veterinario

Zomedica Corp. expands into Costa Rica with SIRE Veterinario as exclusive distributor. Strategic partnership aims to bring adva...

 zomedica-enters-costa-rican-market-sire-veterinario-named-exclusive-distributor

Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care dia...

Core News & Articles

https://x.com/TheRoaringKitty/status/1806371920495186041 

 zomedica-launches-new-cortisol-assay-for-equine-health-on-truforma-platform

 Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and t...

 zomedica-presents-truformar-research-findings-at-major-veterinary-internal-medicine-conference-says--new-research-data-confirms-superiority-of-truformas-bulk-acoustic-wave-sensor-technology-in-diagnosing-feline-hyperthyroidism

The firm announced the presentation of research highlighting the improved diagnostic capabilities of the TRUFORMA® Bulk Acousti...

 zomedica-continues-to-expect-fy24-revenue-of-31m-35m-est-341m

The outlook represents an increase of approximately 39% at the high end of the range, over full year 2023 revenue of $25.2 mill...

 zomedica-secures-ce-certification-for-vetguardian-expanding-access-to-contactless-monitoring-for-vets-in-the-eu

Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care dia...

 zomedica-q4-2023-gaap-eps-002-sales-7337m-beat-7000m-estimate

Zomedica (AMEX:ZOM) reported quarterly losses of $(0.02) per share. The company reported quarterly sales of $7.337 million whi...

 earnings-scheduled-for-april-1-2024

Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION